Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease (Q39658512)
scientific article published on September 7, 2010
Language:
(P31) (Q13442814)
(P50) (Q114063191)
(P304) 4611-4618
(P407) (Q1860)
(P433) 11
(P478) 54
(P577) Tuesday, September 7, 2010
(P921) (Q708693)
(Q154869)
(P953) https://aac.asm.org/content/aac/54/11/4611.full.pdf
http://intl-aac.asm.org/cgi/content/abstract/54/11/4611
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20823284/pdf/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20823284/?tool=EBI
https://europepmc.org/articles/PMC2976164
https://europepmc.org/articles/PMC2976164?pdf=render
https://doi.org/10.1128/aac.00787-10
https://journals.asm.org/doi/pdf/10.1128/AAC.00787-10
(P1433) (Q578004)
(P1476) "Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease" (language: en)
"Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease" (language: en)
(P2093) Montse Llinàs-Brunet
Ma'an Amad
Gordon Bolger
Jianmin Duan
Michel Garneau
Lisette Lagacé
Diane Thibeault
Peter W. White
Richard C. Bethell
Michael G. Cordingley
(P2860) (Q27490545)
(Q37510413)
(Q33420226)
(Q29620138)
(Q24650264)
(Q27487391)
(Q27860957)
(Q29616780)
(Q36477461)
(Q27473228)
(Q27473129)
(Q27473126)
(Q27861119)
(Q27860899)
(Q27470013)
(Q34364260)
(Q29614207)
(Q27472912)
(Q27469559)
(Q36886681)
(Q27733707)
(Q27733705)
(Q27486051)
(Q27480317)
(Q29547463)
(Q27860958)
(Q27860719)
(Q37794779)
(Q35003095)
(Q40967696)
(Q42537150)
(Q42537183)
(Q42541530)
(Q43031852)
(Q42935191)
(Q42993051)
(Q43031767)
(Q42990950)
(Q45040418)
(Q43049051)
(Q43049197)
(Q58789199)
(Q1500272)
other details
description scientific article published on September 7, 2010

External Links